Podcasts about indegene

For episode 34 of the TriloTalk podcast, Lisa Chamberlain James, Senior Partner at Trilogy, sits down with the AI Agent expert Nikesh Shah, VP and Global Head, Generative AI at Indegene. They discuss everything you need to know about AI Agents – the day-to-day usage, project confidentiality, when it will become mainstream, which industries are using it now, and how it will enrich our lives. It's an episode you don't want to miss!  

To get your dose of daily business news, tune into Mint Top of the Morning on Mint Podcasts available on all audio streaming platforms. https://open.spotify.com/show/7x8Nv1RlOKyMV5IftIJwP1?si=bf5ecbaedd8f4ddc This is Nelson John, and I'll bring you the top business and tech stories, let's get started.  Jubilant FoodWorks Bets Big on Tech & Expansion Jubilant FoodWorks is ramping up its Domino's India expansion from 2,000 to 3,000 stores, backed by Elate, an in-house Android-based POS system aimed at improving efficiency across its brands (Domino's, Popeyes, Dunkin', Hong's Kitchen). CEO Sameer Khetarpal promises tech upgrades every six months, integrating AI into store management. The company is also pushing for faster deliveries, with 70% already happening in under 20 minutes and a new guaranteed 20-minute service coming to India's top seven cities. However, dine-in sales remain sluggish as free delivery drives online orders. Meta's Project Waterworth: Building the World's Longest Undersea Cable Meta is advancing Project Waterworth, a 50,000-km undersea cable connecting India, the US, Brazil, South Africa, and more. The aim? Faster internet and AI-driven applications across platforms like Instagram, WhatsApp, and YouTube. Meta is in talks with Airtel, Jio, Tata Communications, and Lightstorm for landing the cable in India, navigating regulatory hurdles. With 95% of global data flowing through subsea cables, this move enhances India's digital backbone while reducing dependence on geopolitically sensitive routes like the Red Sea and South China Sea. Indegene Expands AI-Driven Pharma Solutions in the US & Europe Bangalore-based Indegene is capitalizing on AI in pharma commercialization and regulation, particularly in the US and Europe, where it derives 64% of its revenue. With US pharma firms under pricing pressure, CEO Manish Gupta sees a major opportunity: “Pricing and market access are critical, and our AI-driven solutions can help.” The company has launched Cortex, an AI-powered platform, and is expanding in Europe, with a London center, an Ireland acquisition, and a move into Spain. Since 2010, Indegene has grown from ₹33 crore to ₹2,500 crore and is poised for further scale. Global Investors Shift from US Stocks Amid Tariff Uncertainty Investors are pulling billions from US stocks, redirecting funds to Europe, Asia, and emerging markets due to concerns over US tariff policies. In March alone, European investors withdrew $2.37 billion from US equity ETFs. April 2, Trump's “Liberation Day” tariff plan, threatens new trade tensions, prompting 15 of the world's largest asset managers to reduce US exposure. Goldman Sachs & Barclays have already cut their S&P 500 forecasts for 2025. While some analysts argue US stocks remain attractive, foreign outflows may weaken market performance. Lollapalooza India Booms Despite Industry Challenges The third edition of Lollapalooza India attracted 60,000+ fans with Green Day, Shawn Mendes, and others. While ticket sales hit records, India's live entertainment infrastructure remains weak, lacking dedicated concert venues. “We have to build everything from the ground up,” says Anil Makhija, COO of BookMyShow Live. Diljit Dosanjh's criticism of India's concert ecosystem further highlights these issues. High taxes and ticket resale controversies (e.g., Coldplay's Mumbai show) also pose challenges. Despite this, India's live music market is growing fast, with global artists increasingly making India a tour stop. BookMyShow is pushing for policy changes, better infrastructure, and new festivals like Bandland. “Fans are ready. Artists are ready. Now, the ecosystem needs to catch up,” says Makhija.

The rapidly growing industry of regulatory medical writing calls for a 2025 prediction podcast! Listen up for “What's Hot and What's Not” from our experts Lisa Chamberlain James, Julia Forjanic Klapproth and Sonica Batra and get a glimpse of what Trilogy, an Indegene Company and Indegene will be up to this year.  

Welcome back to TriloTalk! In this episode, Lisa Chamberlain James from Trilogy and Vladimir Penkrat and Ritesh Dogra from Indegene dive into the role and future of lay summaries. AI technology, new EUCTR requirements, graphic creation, and much more will affect how medical writers create patient-friendly language documents. Tune in to gain valuable insights and tips on how to navigate this changing environment.  

Join host Don Davis as he sits down with Tarun Mathur CTO at Indegene, a visionary leader in digital transformation for the life sciences industry. With over two decades of experience, Tarun shares his insights on leveraging AI, machine learning, and cutting-edge technologies to solve complex challenges across the pharmaceutical lifecycle. In this episode, you'll discover: • How AI is reshaping drug development, clinical research, and patient care • Strategies for blending domain expertise with technological innovation • The importance of customer-centric approaches in life sciences • Tarun's philosophy on continuous learning and staying ahead of the curve Whether you're a life sciences professional, tech enthusiast, or curious about the future of healthcare, this conversation offers a fascinating glimpse into the intersection of technology and medicine. Tune in to explore how Tarun and his team at Indegene are paving the way for a more efficient, effective, and patient-focused future in life sciences.   Join us for an insightful episode of the Life Science Success Podcast as we dive into the world of AI and digital transformation with Tarun Mathur, a visionary leader in the life sciences industry. Discover Tarun's journey from his early fascination with coding to his role in revolutionizing pharmaceutical life cycles with AI and machine learning at Indigene.   In this episode, we explore the intersection of domain expertise and technology, the challenges and opportunities in the industry, and the exciting potential of emerging technologies like multimodal models and the metaverse. Whether you're in the life sciences field or just interested in the future of AI, this episode is packed with valuable insights and inspiration.     00:00 Introduction to Life Science Success Podcast 00:31 Sponsor Message: D3 Digital Media Marketing 01:23 Guest Introduction: Tarun Mathur 01:58 Tarun's Early Journey in Technology 04:09 First Foray into Healthcare 04:31 Startup Success and Challenges 06:14 Acquisition by Indigene 08:24 Operational Challenges and Remote Work 13:20 AI in Healthcare: Early Beginnings 21:24 AI and Knowledge Engineering 28:53 The Importance of Trust and Accuracy in Pharma Communication 30:56 Balancing Data Privacy and Effective Marketing 32:40 The Future of AI in Digital Marketing 34:54 Challenges Facing Life Sciences in the Next Decade 40:33 Indigene's Approach to Integrating Domain Knowledge and Technology 48:12 Emerging Technologies and Their Impact 50:49 Personal Inspirations and Ethical Concerns 53:52 Conclusion and Final Thoughts

In this episode, Julia Forjanic Klapproth and Lisa Chamberlain James from Trilogy and Vladimir Penkrat and Tarun Mathur from Indegene chat about the intersection of AI and medical writing. They cover historical evolution, current needs, automation strategies, essential skills, regulatory compliance, and unique use cases. Tune in to catch the insights and join the conversation!  

HFS Research published our HFS Horizon for Life Science Service Providers report, where we evaluated 29 service providers across four dimensions: the Why, What, How, and So What, and then categorized them into three horizons. The study unearthed three key insights. Listen to the conversation between Rohan Kulkarni, Executive Research Leader at HFS Research, and Tarun Mathur, CTO at Indegene, as they reveal the three key insights from the study, and also talk about Indegene's performance, its commitment to improve outcomes, reduce costs, and enhance customer experience. Read the associated HORIZONS REPORT – “HFS Horizons: Life Science Service Providers, 2023" here: https://www.hfsresearch.com/research/hfs-horizons-life-science-service-providers-2023/

Revolutionizing Patient and Physician Experiences through Digital First Strategies - In this week's episode of Life Science Success, we dive into the intersection of digital innovation and healthcare commercialization with leaders from Indegene, a company revolutionizing patient and physician experiences through digital-first strategies. We'll explore the journeys of Nancy Phelan, a biopharma commercial strategy expert; Jeff Rothstein, a marketing visionary who has significantly expanded Indegene's brand and capabilities; and Kevin Patterson, a strategic thinker in medical solutions, as they share insights on driving healthcare forward in today's complex landscape.   Key Takeaways: Interdisciplinary Innovation: The convergence of diverse backgrounds and expertise is driving innovation in healthcare, emphasizing the importance of storytelling and engagement in healthcare marketing. Digital Transformation: The shift towards digital and data-driven strategies is revolutionizing patient and physician experiences, making healthcare more personalized and accessible. AI's Growing Influence: Artificial intelligence is poised to transform healthcare delivery and treatment, with current applications representing just the tip of the iceberg. Navigating Market Access Challenges: Successfully bringing new treatments to market requires overcoming regulatory and accessibility hurdles, highlighting the need for strategic market access planning. Optimism for the Future: Despite challenges, there's a strong sense of optimism about the future of healthcare, driven by technological advancements and a commitment to improving patient care.

In this episode of Pharma Launch Secrets, Bozidar speaks with Nancy Phelan, senior VP at Indegene.

In this episode of Pharma Launch Secrets, Bozidar speaks with Nancy Phelan, senior VP at Indegene.

In this episode of Life Science Success, my guest is Gaurav Kapoor.  Gaurav is a co-founder of Indegene, a digital-first life sciences commercialization company with 19 of the world's top 20 biopharma companies as clients. Gaurav is an expert in life sciences commercialization, having pioneered the co-commercialization model at Indegene. He has close to 25 years of experience in the technology-led healthcare solutions space.   Part 1: Introduction and Background Don Davis: Host of the Life Science Success Podcast, focuses on strategy, people, process, and technology in life sciences. He also has a weekly series on LinkedIn Live about scaling organizations. Gaurav Kapoor: Co-founder of Indegene, a digital-first life sciences commercialization company. They work with 19 of the world's top 20 biopharma companies. Part 2: Journey and Motivation Gaurav Kapoor: Shares his 25-year journey with Indegene. Initially focused on bridging the knowledge gap between doctors and the pharma industry using data and technology. They digitized thousands of hours of content from medical conferences. Part 3: Business Model and Shifts Indegene initially focused on B2C but shifted to a B2B model. They also moved their focus to the U.S. market due to its innovation and concentration of pharma companies. Part 4: Industry Changes and Adaptation Significant industry changes around 2010 due to the patent cliff led to a focus on centralization and compliance. Indegene started reimagining the sales and marketing model around 2015, predicting a shift towards an omni-channel approach. Part 5: Co-Commercialization Indegene pioneered co-commercialization, focusing on an omni-channel sales model and a "launch in a box" platform for mid-pharma and biotech companies. This allows for leaner, more efficient launches and operations. Part 6: Future Outlook Both Don and Gaurav discuss the need for the industry to continue evolving, especially in the wake of the COVID-19 pandemic. They express hope that the new efficiencies and approaches adopted during the pandemic will become the new normal.

In this special compilation episode, we will take you back to revisit some of the most enlightening conversations, innovative strategies, and motivating stories since our beginning.

In this special compilation episode, we will take you back to revisit some of the most enlightening conversations, innovative strategies, and motivating stories since our beginning.

In this episode, Bozidar speaks with Sameer Lal, SVP at Indegene.

In this episode, Bozidar speaks with Sameer Lal, SVP at Indegene.

Marc Iskowitz interviews Indegene's Jack Mycka, VP of enterprise medical solutions and emerging biotech at Indegene, for his take on developments that have reset the drug-price “chessboard.” For her policy update, Lecia Bushak recaps a Senate hearing on PBMs and explains why a federal judge's ACA ruling has the White House playing defense. And Jack O'Brien explores the TikTok hype around “face taping,” an anti-aging experiment that may not be so benign. Music by Sixieme Son.  Follow us on twitter: @MMMnewsJoin us at MM+M Transform: The New Era of Connectivity for an in-depth look at trends likely to inform the industry's evolution over the next 18 months. Now in its ninth year, MM+M's full-day, in-person program will bring together marketing leaders to discuss the need to forge stronger connections along the patient journey, the effective use of data in managing health conditions and the next iteration of tech-forward devices and diagnostics. MM+M will also host curated networking opportunities during which attendees can connect and share insight, along with raffles where attendees can win Yankees tickets, an Apple Watch, AirPods and more! www.mmmtransform.com

In this episode, Bozidar is joined by Gaurav Kapoor, Executive Vice President of Indegene to share how Life Sciences companies reimagine commercialization in 2023 in the Digital-First Reality.

In this episode, Bozidar is joined by Gaurav Kapoor, Executive Vice President of Indegene to share how Life Sciences companies reimagine commercialization in 2023 in the Digital-First Reality.

In this episode of Pharma Launch Secrets, Bozidar is joined by Peter Marchesini, Senior Vice President at Indegene.

In this episode of Pharma Launch Secrets, Bozidar is joined by Peter Marchesini, Senior Vice President at Indegene.

Indegene was founded in an era when VC money was not flowing. Manish talks about Indegene's journey of sustainable scaling, starting with helping pharma companies with content and training to eventually becoming the full-stack behemoth that it is today with a few acquisitions along the way. This episode is a masterclass in sustainably scaling a global business!Know about:- Medical representative as a service Difference between CSO and a VSO Past acquisitions Trends in pharma post-pandemicClick to read the text version of the episode

Milesh Gogad is CMO at Indegene, a digital-first life sciences commercialization company. They help life sciences companies develop products, get them to the market and grow their impact through the life cycle in a more effective, efficient, and modern way.Milesh was previously CMO at GE Aviation Digital before joining Indegene in 2020.We discuss:The role of marketing and how it is used at IndegeneHow to articulate the value of brand to your leadership teamWhat building a purpose-driven brand is all aboutHow to implement and build strong team culture Mentioned in this episode:Brought to you by CMO Crowd and The Marketing PracticeFind out more at cmocrowd.com

Milesh Gogad is CMO at Indegene, a digital-first life sciences commercialization company. They help life sciences companies develop products, get them to the market and grow their impact through the life cycle in a more effective, efficient, and modern way.Milesh was previously CMO at GE Aviation Digital before joining Indegene in 2020.We discuss:The role of marketing and how it is used at IndegeneHow to articulate the value of brand to your leadership teamWhat building a purpose-driven brand is all aboutHow to implement and build strong team culture

Preferential treatment for orphan drugs is very much in play overseas. Pricing guru Jack Mycka, VP in the PRMA division of Indegene, explains what potential European reforms could mean for pharma marketers in light of U.S. pressure to reform drug pricing.

From an ahead-of-its-times outfit to bring technology to 'medico marketing' to a multinational tech company offering AI and NLP platforms to the world's biggest drugmakers, Indegene has come a long way. The Covid-19 pandemic, however, showed that the Bengaluru company was only getting started. In this special briefing, Manish Gupta, co-founder and CEO of Indegene, recalls the early days of Indegene, and talks about what lies ahead

https://www.youtube.com/watch?v=5XJwIzY5agY

Today's episode is the third in our series on women's participation in the workforce in India. Every year, class XII grades show girls outperforming boys in science subjects. A McKinsey study, shows that in India women make up 43% of those graduating but only 25% of those in entry level jobs. That is a huge drop. There are many explanations including marriage, childbirth, care for elders, being the trailing spouse, safety, and all of this compounds as you go higher in the career ladder. The burden of childcare and elder care almost entirely falls on women. The effect shows on the labor participation rate. At an effective 11% participation in manufacturing and services, we trail many mature and emerging countries. For some time now, I've brought you individual stories of guests with outsized abilities and wisdom. So, in a break from tradition, today, I bring you a panel discussion with 3 leaders, who have the unique distinction of being able to shape the participation of women at work in India and with a different perspective and background. Joining me are Hema Hattangady, former CEO of Conzerv, an Indian family-owned enterprise acquired by Schneider Electric, who sits on the board of multiple companies and an alumnus of IIM Calcutta, Dr. Murali Padmanabhan, Senior VP for Global Talent & OD at Virtusa, leadership coach and a PhD in Applied Mathematics from the University of Hyderabad and Shonalie Gupta, Senior Director Organization Development at Indegene, diversity and inclusion coach and an alumnus of XLRI, Jamshedpur. In this episode, we discuss awareness of India's dismal female participation, societal stereotypes, and challenges. But that is not all. We go further and give you practical, tested, tips and ideas on how to have the conversation around increasing female labor participation, beginning with small changes at an individual level to large scale organization impact. To cap it off, each of the panelists include their wish list of how they see corporate India 20 years from now. Go on, grab a cuppa joe, a note pad and tune in. Read a transcript of this interview at: https://www.tellitlikeitispodcast.com/post/s5-e4-bonus-women-at-work-in-india-tell-it-like-it-is Recommended reading: The future of women at work by McKinsey Global Institute Skills development of women through vocational training by Nikita Diwakar & Tauffiqu Ahamad: https://www.researchgate.net/publication/290691361_Skills_development_of_women_through_vocational_training Women in the workplace by Lean In & McKinsey: https://womenintheworkplace.com/ --- Send in a voice message: https://anchor.fm/manisha-kadagathur/message

My guest today is Manish Gupta, co-founder, and CEO of Indegene, a 3000 member global health solutions company specializing in research, content and data solutions to the pharma industry worldwide leveraging analytics and AI. The pharma industry, a highly regulated one, lends itself to the use of AI and digital capabilities since vast data sets exist across the product life cycle and therefore, the genius in spotting this opportunity. We cover: - Building a global company from India, raising capital from early investors, strength of the core team; - Pivoting when faced by the headwinds of the dotcom bust and patent cliff; - Inflection points and how those translated into opportunities; - Clarity of purpose, outsized ambition, precision, and an easy vibe as a leader If you are interested in the life sciences industry and get your kicks from applying digital and AI solutions to solve for problems, check Indegene out. They're hiring. --- Send in a voice message: https://anchor.fm/manisha-kadagathur/message

In this webinar, we have Mr. Nikhil Kumar talking about how to handling Social Media effectively During COVID-19. Nikhil is the Head of Marketing & Content at Esseplore Pte Ltd and has been recognised as one of the world's top “100 Smartest Digital Marketing Leaders” by CMOAsia & the World Digital Marketing Congress in Jan 2019. He has 14 years of experience in strategising, planning, and executing award-winning social media and digital marketing programs across verticals. In his previous role, he was the Head of Digital, Social Media and Analytics practice at Cafe Coffee Day, Brave New World - an integrated communications agency, Ogilvy & Mather and Indegene.

Dr. Destry Sulkes has held executive positions in healthcare IT settings for over 15 years, including roles as Managing Director at Medsn, Inc., since acquired by Indegene, Managing Director at MedsiteCME, a subsidiary of Medsite, Inc., and Vice President of Medical Affairs and Strategy at WebMD. His research is published in leading peer-reviewed medical journals such as The American Journal of Medicine, The American Journal of Cardiology, Archives of Ophthalmology, Retina, and others. Dr. Sulkes holds a BA from Dartmouth College and a joint MD/MBA with research honors from Tufts University School of Medicine. He currently serves in voluntary roles as President of the Board of Directors at the Alliance for Continuing Education in the Healthcare Professions, and as a Mentor for the Blueprint Health accelerator program for healthcare IT start-ups. Dr. Sulkes is currently the Co-Founder and Executive Vice President at Medivo, a company dedicated to simplifying and transforming health.In this interview, Dr. Sulkes discuss several critical topics in health care today, including transparency, patient education, value, HIPAA, leadership, and his path through Alaska!